--- title: "China Regenerative Medicine International (8158) stock" url: "https://aibio.space/companies/china-regenerative-medicine-international/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "China Regenerative Medicine International Limited (HKEX: 8158), Hong Kong. The directory classifies it as Pharmaceuticals: Major." --- 8158 China Regenerative Medicine International Limited HKEX · Hong Kong # China Regenerative Medicine International (8158) news China Regenerative Medicine International Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 8158, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest China Regenerative Medicine International news We have not published a story on China Regenerative Medicine International yet. When there is news, it will appear here. ## China Regenerative Medicine International at a glance - **Ticker**: 8158 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [Regencell Bioscience Holdings](https://aibio.space/companies/regencell-bioscience/) NASDAQ: RGC - [Beijing Tong Ren Tang Chinese Medicine Co.](https://aibio.space/companies/beijing-tong-ren-tang-chinese-medicine/) HKEX: 3613 - [Grand Pharmaceutical Group](https://aibio.space/companies/grand-pharmaceutical/) HKEX: 512 - [HUTCHMED (China)](https://aibio.space/companies/hutchmed-china/) HKEX: 13 - [Tianda Pharmaceuticals](https://aibio.space/companies/tianda-pharmaceuticals/) HKEX: 455 - [InSilico Medicine Cayman TopCo](https://aibio.space/companies/insilico-medicine-cayman-topco/) HKEX: 3696 - [Regent Pacific Group](https://aibio.space/companies/regent-pacific/) HKEX: 575 - [Shenzhen Neptunus Interlong Bio-Technique Co.](https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/) HKEX: 8329 ### Also on HKEX - [CF PharmTech](https://aibio.space/companies/cf-pharmtech/) 2652 - [Zhaoke Ophthalmology](https://aibio.space/companies/zhaoke-ophthalmology/) 6622 - [Shanghai Bao Pharmaceuticals Co](https://aibio.space/companies/shanghai-bao-pharmaceuticals/) 2659 - [Frontage Holdings](https://aibio.space/companies/frontage/) 1521 - [BioDlink International Company](https://aibio.space/companies/biodlink-international/) 1875 - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) 8037 ## Questions about China Regenerative Medicine International What is the ticker symbol of China Regenerative Medicine International? China Regenerative Medicine International Limited trades under the ticker 8158 on HKEX. Where is China Regenerative Medicine International listed? China Regenerative Medicine International Limited is listed on HKEX. Which country or territory is China Regenerative Medicine International listed under? Our directory records China Regenerative Medicine International Limited under Hong Kong. What does China Regenerative Medicine International do? Our directory classifies China Regenerative Medicine International Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of China Regenerative Medicine International? The ISIN recorded for China Regenerative Medicine International Limited is KYG2129W1380. Does aibio.space cover China Regenerative Medicine International? aibio.space lists China Regenerative Medicine International Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to China Regenerative Medicine International? Companies in our directory listed in the same country and business area as China Regenerative Medicine International: Regencell Bioscience Holdings, Beijing Tong Ren Tang Chinese Medicine Co., Grand Pharmaceutical Group, HUTCHMED (China), Tianda Pharmaceuticals, InSilico Medicine Cayman TopCo. ## Investor discussion: China Regenerative Medicine International Members talk about China Regenerative Medicine International (8158). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at China Regenerative Medicine International, newest first. Each line links the filing it comes from. 1. 2026-06-02 Financings Share or debt issue: PROPOSAL FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) EXTENSION OF GENERAL MANDATE TO ISSUE SHARES; (3) RE-ELECTION OF THE RETIRING DIRECTORS; (4) PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (5) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0602/2026060202284.pdf) 2. 2025-12-24 Mergers Transaction under the Listing Rules: (1) MAJOR TRANSACTIONS IN RELATION TO THE OUTSTANDING PAYMENT AGREEMENT AND THE MEMBERSHIP TRANSFER AGREEMENTS; AND (2) BREACH OF GEM LISTING RULES. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1224/2025122400229.pdf) 3. 2025-12-05 Mergers Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR AND GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 19.41(a) OF THE GEM LISTING RULES. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1205/2025120501579.pdf) 4. 2025-11-21 Mergers Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR REGARDING (1) MAJOR TRANSACTIONS IN RELATION TO THE OUTSTANDING PAYMENT AGREEMENT AND THE MEMBERSHIP TRANSFER AGREEMENTS; AND (2) BREACH OF GEM LISTING RULES. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1121/2025112101063.pdf) 5. 2025-11-18 Mergers Transaction under the Listing Rules: VOLUNTARY ANNOUNCEMENT FORMAL TERMINATION OF THE DISCLOSEABLE TRANSACTION IN RELATION TO THE SUBSCRIPTION OF INCREASED REGISTERED CAPITAL IN THE TARGET COMPANY. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1031/2025103101974.pdf) 6. 2025-10-31 Mergers Transaction under the Listing Rules: (1) MAJOR TRANSACTIONS IN RELATION TO THE OUTSTANDING PAYMENT AGREEMENT AND THE MEMBERSHIP TRANSFER AGREEMENTS; AND (2) BREACH OF GEM LISTING RULES. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1031/2025103101988.pdf) 7. 2025-06-03 Financings Share or debt issue: PROPOSAL FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) EXTENSION OF GENERAL MANDATE TO ISSUE SHARES; (3) RE-ELECTION OF THE RETIRING DIRECTORS; (4) TERMINATION OF THE EXISTING SHARE OPTION SCHEME AND PROPOSED ADOPTION OF THE NEW SHARE OPTION SCHEME; AND (5) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2025/0603/2025060302431.pdf) 8. 2024-11-01 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RESPECT OF THE TENANCY AGREEMENT OF THE PREMISES. [Source](https://www1.hkexnews.hk/listedco/listconews/gem/2024/1101/2024110103505.pdf) ## Press releases Headlines of China Regenerative Medicine International's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-25 HKEXnews [RESIGNATION OF AUDITOR](https://www1.hkexnews.hk/listedco/listconews/gem/2026/1025/2026102500029.pdf) 2. 2026-09-17 HKEXnews [Letter to Non-registered Shareholder - New Arrangements on Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0917/2026091700825.pdf) 3. 2026-09-17 HKEXnews [Letter to Registered Shareholder - New Arrangements on Dissemination of Corporate Communications and Reply Form](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0917/2026091700809.pdf) 4. 2026-08-21 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0821/2026082100989.pdf) 5. 2026-06-26 HKEXnews [Memorandum and Articles of Association](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0626/2026062601213.pdf) 6. 2026-06-26 HKEXnews [POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0626/2026062601206.pdf) 7. 2026-06-12 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0612/2026061200852.pdf) 8. 2026-06-02 HKEXnews [Notification Letter to Non-Registered Shareholders - Notice of Publication of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0602/2026060202348.pdf) 9. 2026-06-02 HKEXnews [Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0602/2026060202326.pdf) 10. 2026-06-02 HKEXnews [NOTICE OF AGM](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0602/2026060202297.pdf) 11. 2026-06-02 HKEXnews [PROPOSAL FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) EXTENSION OF GENERAL MANDATE TO ISSUE SHARES; (3) RE-ELECTION OF THE RETIRING DIRECTORS; (4) PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (5) NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0602/2026060202284.pdf) 12. 2026-04-30 HKEXnews [PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0430/2026043002419.pdf) 13. 2026-03-30 HKEXnews [ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0330/2026032702334.pdf) 14. 2026-03-27 HKEXnews [VOLUNTARY ANNOUNCEMENT INTERNAL CONTROL REVIEW - (1) COMPLETION OF IMPLEMENTATION OF THE REMEDIAL ACTIONS; AND (2) RESULTS OF THE FOLLOW-UP REVIEW](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0327/2026032702750.pdf) 15. 2026-03-25 HKEXnews [POSITIVE PROFIT ALERT](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0325/2026032501827.pdf) 16. 2026-01-02 HKEXnews [VOLUNTARY ANNOUNCEMENT - STRATEGIC COOPERATION](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0102/2026010202828.pdf) 17. 2025-12-24 HKEXnews [DOCUMENTS ON DISPLAY](https://www1.hkexnews.hk/listedco/listconews/gem/dod/en.html) 18. 2025-12-24 HKEXnews [(1) MAJOR TRANSACTIONS IN RELATION TO THE OUTSTANDING PAYMENT AGREEMENT AND THE MEMBERSHIP TRANSFER AGREEMENTS; AND (2) BREACH OF GEM LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1224/2025122400229.pdf) 19. 2025-12-05 HKEXnews [DELAY IN DESPATCH OF CIRCULAR AND GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 19.41(a) OF THE GEM LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1205/2025120501579.pdf) 20. 2025-11-21 HKEXnews [DELAY IN DESPATCH OF CIRCULAR REGARDING (1) MAJOR TRANSACTIONS IN RELATION TO THE OUTSTANDING PAYMENT AGREEMENT AND THE MEMBERSHIP TRANSFER AGREEMENTS; AND (2) BREACH OF GEM LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1121/2025112101063.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:8158 on TradingView](https://www.tradingview.com/symbols/HKEX-8158/). ## Listing details China Regenerative Medicine International Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 8158, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: China Regenerative Medicine International Limited - **Ticker**: 8158 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG2129W1380 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-8158/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/china-regenerative-medicine-international/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "China Regenerative Medicine International (8158) stock", 2026-10-31, https://aibio.space/companies/china-regenerative-medicine-international/